{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:33:21Z","timestamp":1774326801482,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T00:00:00Z","timestamp":1452816000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP93601"],"award-info":[{"award-number":["MOP93601"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alberta Prion Research Institute","award":["APRI 201400009"],"award-info":[{"award-number":["APRI 201400009"]}]},{"DOI":"10.13039\/501100000145","name":"Alberta Innovates - Health Solutions","doi-asserted-by":"publisher","award":["Visiting Scientist award 201401129"],"award-info":[{"award-number":["Visiting Scientist award 201401129"]}],"id":[{"id":"10.13039\/501100000145","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s12035-016-9684-x","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T08:16:36Z","timestamp":1452845796000},"page":"748-754","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Pramlintide Antagonizes Beta Amyloid (A\u03b2)- and Human Amylin-Induced Depression of Hippocampal Long-Term Potentiation"],"prefix":"10.1007","volume":"54","author":[{"given":"R.","family":"Kimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"MacTavish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Westaway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack H.","family":"Jhamandas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,15]]},"reference":[{"key":"9684_CR1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.pathol.1.110304.100113","volume":"1","author":"DM Skovronsky","year":"2006","unstructured":"Skovronsky DM, Lee VM, Trojanowski JQ (2006) Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu Rev Pathol 1:151\u2013170","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"9684_CR2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth HW, LaFerla FM (2010) Alzheimer\u2019s disease. N Engl J Med 362(4):329\u2013344","journal-title":"N Engl J Med"},{"key":"9684_CR3","first-page":"204","volume":"148","author":"Y Huang","year":"2012","unstructured":"Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148:204\u2013222","journal-title":"Cell"},{"key":"9684_CR4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1146\/annurev.ne.17.030194.002421","volume":"17","author":"D Selkoe","year":"1994","unstructured":"Selkoe D (1994) Normal and abnormal biology of the \u03b2-amyloid precursor protein. Annu Rev Neurosci 17:489\u2013517","journal-title":"Annu Rev Neurosci"},{"key":"9684_CR5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297:353\u2013356","journal-title":"Science"},{"key":"9684_CR6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/ana.24001","volume":"74","author":"DJ Selkoe","year":"2013","unstructured":"Selkoe DJ (2013) The therapeutics of Alzheimer\u2019s disease: where we stand and where we are heading. Ann Neurol 74:328\u2013336","journal-title":"Ann Neurol"},{"key":"9684_CR7","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1471-4159.2009.06181.x","volume":"110","author":"J Hardy","year":"2009","unstructured":"Hardy J (2009) The amyloid hypothesis for Alzheimer\u2019s disease: a critical reappraisal. J Neurochem 110:1129\u20131134","journal-title":"J Neurochem"},{"key":"9684_CR8","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A et al (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease. Nature 349:704\u2013706","journal-title":"Nature"},{"key":"9684_CR9","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1073\/pnas.94.9.4772","volume":"94","author":"S Dore","year":"1997","unstructured":"Dore S, Kar S, Quirion R (1997) IGF-I protects and rescues hippocampal neurones against \u03b2-amyloid and human amylin-induced toxicity. Proc Natl Acad Sci U S A 94:4772\u20134777","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9684_CR10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1749-6632.2000.tb06920.x","volume":"920","author":"DL Price","year":"2000","unstructured":"Price DL, Wong PC, Markowska AL, Lee MK, Thinakaren G, Cleveland DW, Sisodia SS, Borchelt DR (2000) The value of transgenic models for the study of neurodegenerative diseases. Ann N Y Acad Sci 920:179\u2013191","journal-title":"Ann N Y Acad Sci"},{"issue":"35","key":"9684_CR11","doi-asserted-by":"crossref","first-page":"32046","DOI":"10.1074\/jbc.M201750200","volume":"277","author":"KN Dahlgren","year":"2002","unstructured":"Dahlgren KN, Manelli AM, Stine WB, Baker LK, Krafft GA, LaDu MJ (2002) Oligomeric and fibrillar species of amyloid-\u03b2 peptides differentially affect neuronal viability. J Biol Chem 277(35):32046\u201332053","journal-title":"J Biol Chem"},{"key":"9684_CR12","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1523\/JNEUROSCI.1051-04.2004","volume":"24","author":"JH Jhamandas","year":"2004","unstructured":"Jhamandas JH, MacTavish D (2004) Antagonist of the amylin receptor blocks \u03b2-amyloid toxicity in rat cholinergic basal forebrain neurons. J Neurosci 24:5579\u20135584","journal-title":"J Neurosci"},{"key":"9684_CR13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ajpath.2010.11.022","volume":"178","author":"JH Jhamandas","year":"2011","unstructured":"Jhamandas JH, Li Z, Westaway D, Yang J, Jassar S, MacTavish D (2011) Actions of \u03b2-amyloid protein on human neurons are expressed through the amylin receptor. Am J Pathol 178:140\u2013149","journal-title":"Am J Pathol"},{"key":"9684_CR14","first-page":"8820","volume":"287","author":"W Fu","year":"2012","unstructured":"Fu W, Ruangkittisakul A, MacTavish D, Shi J, Ballanyi K, Jhamandas JH (2012) Amyloid beta (A\u03b2) peptide directly activates amylin-3 receptor subtype by triggering multiple intracellular signalling pathways. J Biol Chem 287:8820\u201318830","journal-title":"J Biol Chem"},{"issue":"38","key":"9684_CR15","first-page":"1","volume":"5","author":"J G\u00f6tz","year":"2013","unstructured":"G\u00f6tz J, Lim Y-A, Eckert A (2013) Lessons from two prevalent amyloidoses\u2014what amylin and A\u03b2 have in common. Front Aging Neurosci 5(38):1\u201310","journal-title":"Front Aging Neurosci"},{"key":"9684_CR16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1054-3589(05)52003-9","volume":"52","author":"A Young","year":"2005","unstructured":"Young A (2005) Receptor pharmacology. Adv Pharmacol 52:47\u201365","journal-title":"Adv Pharmacol"},{"key":"9684_CR17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10495-011-0656-3","volume":"17","author":"JH Jhamandas","year":"2012","unstructured":"Jhamandas JH, MacTavish D (2012) \u03b2-amyloid protein (A\u03b2) and human amylin regulation of apoptotic genes occurs through the amylin receptor. Apoptosis 17:37\u201347","journal-title":"Apoptosis"},{"issue":"5","key":"9684_CR18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0031-9384(00)00302-4","volume":"70","author":"TA Lutz","year":"2000","unstructured":"Lutz TA, Tschudy S, Rushing PA, Scharrer E (2000) Attenuation of anorectic effects of cholecystokinin and bombesin by the specific amylin antagonist AC253. Physiol Behav 70(5):533\u2013536","journal-title":"Physiol Behav"},{"key":"9684_CR19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.phrs.2007.03.001","volume":"56","author":"G Cantarella","year":"2007","unstructured":"Cantarella G, Martinez G, Di-Benedetto G, Loreto C, Musumeci G, Prato A, Lempeeur L, Matera M et al (2007) Protective effects of amylin on reserpine-induced gastric damage in the rat. Pharmacol Res 56:27\u201334","journal-title":"Pharmacol Res"},{"key":"9684_CR20","doi-asserted-by":"crossref","first-page":"17401","DOI":"10.1523\/JNEUROSCI.3028-12.2012","volume":"32","author":"R Kimura","year":"2012","unstructured":"Kimura R, MacTavish D, Yang J, Westaway D, Jhamandas JH (2012) Beta amyloid-induced depression of hippocampal long-term potentiation is mediated through the amylin receptor. J Neurosci 32:17401\u201317406","journal-title":"J Neurosci"},{"issue":"4","key":"9684_CR21","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.neurobiolaging.2013.10.076","volume":"35","author":"BL Adler","year":"2013","unstructured":"Adler BL, Yarchoan M, Hwang HM, Louneva N, Blair JA, Palm R, Smith MA, Lee HG et al (2013) Neuroprotective effects of the amylin analogue pramlintide on Alzheimer\u2019s disease pathogenesis and cognition. Neurobiol Aging 35(4):793\u2013801","journal-title":"Neurobiol Aging"},{"key":"9684_CR22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/mp.2014.17","volume":"20","author":"H Zhu","year":"2015","unstructured":"Zhu H, Wang X, Wallack M, Li H, Carreras I, Dedeoglu A, Hur JY, Zheng H et al (2015) Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer\u2019s disease. Mol Psychiatry 20:252\u2013262","journal-title":"Mol Psychiatry"},{"key":"9684_CR23","doi-asserted-by":"crossref","first-page":"21562","DOI":"10.1074\/jbc.M100710200","volume":"276","author":"MA Chishti","year":"2001","unstructured":"Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, Pearson J, Strome R, Zuker N et al (2001) Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein. J Biol Chem 276:21562\u201321570","journal-title":"J Biol Chem"},{"key":"9684_CR24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1471-4159.2010.06608.x","volume":"113","author":"R Kimura","year":"2010","unstructured":"Kimura R, Devi L, Ohno M (2010) Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer\u2019s disease transgenic mice. J Neurochem 113:248\u2013261","journal-title":"J Neurochem"},{"key":"9684_CR25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.nbd.2008.10.006","volume":"33","author":"R Kimura","year":"2009","unstructured":"Kimura R, Ohno M (2009) Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model. Neurobiol Dis 33:229\u2013235","journal-title":"Neurobiol Dis"},{"key":"9684_CR26","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1074\/jbc.M210207200","volume":"278","author":"WB Stine Jr","year":"2003","unstructured":"Stine WB Jr, Dahlgren KN, Krafft GA, LaDu MJ (2003) In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J Biol Chem 278:11612\u201311622","journal-title":"J Biol Chem"},{"key":"9684_CR27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1098-2299(199604)37:4<231::AID-DDR5>3.0.CO;2-M","volume":"37","author":"AA Young","year":"1996","unstructured":"Young AA, Vine W, Gedulin BR, Pittner R, Janes S, Caeta LSN, Percy A, Moore CX et al (1996) Preclinical pharmacology of pramlintide in the rat: comparisons with human and rat amylin. Drug Dev Res 37:231\u2013248","journal-title":"Drug Dev Res"},{"key":"9684_CR28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1210\/en.2013-1658","volume":"155","author":"JJ Gingell","year":"2014","unstructured":"Gingell JJ, Burns ER, Hay DL (2014) Activity of pramlintide, rat and human amylin but not A\u03b21\u201342 at human amylin receptors. Endocrinology 155:21\u201326","journal-title":"Endocrinology"},{"key":"9684_CR29","doi-asserted-by":"crossref","unstructured":"Wang H, Abedini A, Ruzsicska B, Raleigh DP (2014) Rationally designed, nontoxic, nonamyloidogenic analogues of human islet amyloid polypetide with improved solubility. Biochemistry","DOI":"10.1021\/bi500592p"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9684-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-016-9684-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9684-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9684-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:48:10Z","timestamp":1559429290000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-016-9684-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,15]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["9684"],"URL":"https:\/\/doi.org\/10.1007\/s12035-016-9684-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,15]]}}}